Novartis | L'Utile Operativo



Operating Profit Cambiamento Data
AbbVie USD 3.73B 5.22B 2025-03
Amgen USD 1.29B 1.02B 2025-03
AstraZeneca USD 3.67B 1.64B 2025-03
Bausch Health Companies USD 276M 332M 2025-03
Biogen USD 311.2M 130.2M 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Canopy Growth CAD -23822000 21.8M 2024-12
Corcept Therapeutics USD 3.42M 21.85M 2025-03
Drreddys Laboratories INR 18.72B 1.17B 2024-12
Eli Lilly USD 5.41B 259.6M 2025-03
Gilead Sciences USD 2.24B 215M 2025-03
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
Glaxosmithkline GBP 702M 513M 2024-12
Indivior 66M 226M 2025-03
J&J USD 13.63B 9.74B 2025-03
Merck USD 5.87B 1.57B 2025-03
Novartis USD 2.28B 1.34B 2024-12
Novartis USD 3.4B 193M 2024-12
Pacira USD 1.99M 22.71M 2025-03
Perrigo USD 112.7M 37.4M 2024-12
Pfizer USD 3.67B 4.08B 2025-03
Prestige Brands USD 88.43M 3.53M 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 2.28B 1.42B 2025-03
Sanofi EUR 861M 2.77B 2024-12
Supernus Pharmaceuticals USD 21.4M 19.44M 2024-12
Zoetis USD 810M 78M 2025-03



Novartis L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.